EXPRESSION AND PROGNOSTIC EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER

Chen Gang
1999-01-01
Abstract:Objective:To investigate expression of proliferating cell nuclear antigen (PCNA) in transitional cell carcinoma (TCC) of the urinary bladder and its relation to prognosis Methods:Anti-PCNA monoclonal antibody PC10 was used to stain PCNA in routine paraffin-embedded sections from TCC. Results:Positive staining was found in 95.8% of bladder cancer (46/48), but in none of normal tissues. The mean PCNA labelling index(LI) were (8.288.68)% in pathologic grade ,(23.8213.02)% in and (44.6824.65)% in , while the values were (12.5812.33)% and (34.5521.89)% in clinical stages TaT1 and T2T4 respectively. There were statistically significant differences in PCNA LI between tumours of different grads and stages( P 0.01).To compare PCNA index and survival, patients were divided into two groups depending on the median level of PCNA staining: the high PCNA group, for which the PCNA LI was greater than 21%, and the low PCNA group, for which the index was less than 21%. The survival rate was calculated using the Log . We found the prognosis of the high PCNA group to be significantly worse than that of the low PCNA group( P 0.01). Conclusion: The expression of PCNA showed colse relation with histopathologic grade, clinical stage and prognosis in TCC, can be suggested to be effective as a prognostic indicator in TCC.
What problem does this paper attempt to address?